Emm has raised £6.8m in an oversubscribed seed funding round to bring the world’s first smart menstrual cup and connected app to market.

Emm will equip users to understand their individual menstrual baseline and track key metrics for personalised, actionable insights into their menstrual health.

The round was led by Lunar Ventures, with additional participation from the Labcorp Venture Fund, Tiny VC, BlueLion Global, Alumni Ventures (investor in Oura & Levels), and a network of high-profile angels, including Amar Shah (co-founder of Wayve), Vivek Garipalli (founder of Clover Health and Wormhole Capital), and Harpreet Rai (former CEO, Oura). Emm has also received non-dilutive funding, including grants that support innovation in women’s health technology.

Despite affecting half the global population, menstrual and women’s reproductive health remain among the most under-served areas in healthcare. 1 in 3 women will experience severe menstrual or reproductive health symptoms in their lifetime, yet both clinicians and individuals lack reliable tools for baseline measurement and tracking until now.

Emm is addressing this gap with a breakthrough wearable device that objectively measures menstrual flow volume and tracks key cycle metrics, such as duration, frequency and regularity – offering users accurate, personalised health insights for the first time, together with an absolute commitment to privacy.